This category celebrates advancements in technologies, products, processes, and services designed to mitigate the effects of global healthcare emergencies on individuals, patients, healthcare professionals, and communities. It recognises innovations such as drug and device development, rapid response initiatives, medical equipment, and the introduction of services, solutions, and resources aimed at addressing the impact of past and potential healthcare crises. 

2025 finalists:

• Custom, cell-free, synthetic DNA - including high complexity sequences, multi kilobase length and milligram scale - made in days to weeks,
  NunaBio Ltd
• Orgovyx – Transforming Prostate Cancer Care Through Accelerated Innovation
  Accord Healthcare
• Room Temperature-Stable Generic Posaconazole Injection Using hydroxypropyl beta-cyclodextrin (HPβCD) – A Safer, Cost-Effective Alternative to Innovator’s Refrigerated Formulation
  Invengene Private Limited
• Ulenistamab - A targeted MAB for Pancreatic Cancer
  Prestige Biopharma
• GMP-Grade CleanCap® M6 Analog
  TriLink BioTechnologies
• Mono Material Drug Delivery Demonstrator
  Covestro Deutschland AG

This category celebrates innovation in technologies, products, processes, and services related to the development and manufacture of active pharmaceutical ingredients. It encompasses but is not limited to, advancements in synthesis, characterisation, scale-up, software and database development, and bulk manufacturing. 

2025 finalists:

• TAPS: TAG Assisted Peptide Synthesis
  CordenPharma International
• Design2Optimize (TM)
  Lonza
• mPredict Co-crystal Prediction Service
  Merck KgaA, Darmstadt, Germany
• From Crystallisation to Tablet: A Scalable Platform for API Agglomeration
  CMAC
  

This award celebrates companies, individuals, and initiatives that prioritise philanthropic, ethical, and community-driven efforts. We welcome entries that focus on patient engagement and centricity, promote corporate social responsibility, and improve healthcare accessibility or equity.

2025 finalists:

• Talent without barriers: CNX's inclusive recruitment programme with the Social Mobility Foundation
  CNX Therapeutics (and the Social Mobility Foundation)
• Elevating Patient Safety Through Intelligent Design
  PharmEvo Pvt. Ltd.
• Resilient by Design: Farmak Group’s Ukrainian-Rooted Pharma Network Blueprint for Crisis-Proof Global Supply
  Farmak International
• Enhancing Access to Affordable Healthcare - HIV
  Strides
• A Decade of Impact with International Health Partners (IHP)
  Accord Healthcare

This category celebrates innovation in technologies, products, solutions, processes, and services related to drug delivery, routes of administration, and device innovation. It includes but is not limited to, advancements in inhalers, auto-injectors, pre-filled syringes, patches, combination products, intelligent packaging, and connected devices.

2025 finalists:

• The YpsoLoop™ Autoinjector -  True circularity and intuitive usability in pre-filled injection devices
  Ypsomed
• The device component of the first biosimilar in an on-body Injector
  LTS Lohmann Therapie Systems AG
  
• Maggie® Mix
  SHL Medical
  
• Advanced Peristomal Barrier & Adhesion Cream (Topical Medical Device)
  Azelis Group NV
  

This category celebrates innovation in technologies, products, processes, and services related to the formulation of drug products. It includes but is not limited to, advancements in excipients, finished dosage forms, OTC products, novel software and digitalisation, process development, overcoming formulation challenges, bioavailability enhancement, drug targeting, controlled release, and stabilisation technologies.

2025 finalists:

• EUDRACAP® colon – The world’s first functional ready-to-fill capsule for oral drug delivery to target the ileo-colonic region
  Evonik Industries AG
• Innovaform® Innovation and Formulation Accelerator
  Lonza Capsules & Health Ingredients
• Modified Supercritical Anti-Solvent (mSAS®) particle engineering for stabilisation of biomolecules
  (CrystecPharma)
• ReadiLYCOAT® Plant-Based Coating Systems: Innovating Drug Formulation with Sustainable Hydroxypropyl Pea Starch Film Coating System for Enhanced Oral Dosage Solutions
  Roquette
• Dispersome® technology
  Zerion Pharma A/S

This category celebrates innovation in technologies, processes, and services for the manufacture of solid, semi-solid, parenteral, inhalation, or other dosage forms. It includes but is not limited to, advancements in equipment, manufacturing approaches, digitalisation, manufacturing processes, facilities, tech transfer, and process controls. We welcome entries from both small and large molecule manufacturing. 

2025 finalists:

• EnzeneX™ - Fully-connected continuous manufacturing™
  Enzene
• Advanced Lyophilization Modelling: Redefining Process Excellence in Biomanufacturing
  Coriolis Pharma Research GmbH
• VectorBuilder's CDMO Platform
  VectorBuilder
• GENEX
  Bausch+Ströbel SE + Co. KG

This category celebrates innovation in technologies, products, processes, equipment, and services for primary, secondary, and tertiary packaging solutions, as well as the packaging and assembly of finished drug products. It includes but is not limited to, advancements in vials, ampules, blister packs, cartons, containers, tamper-proof packaging, labeling systems, track and trace technologies, anti-counterfeiting measures, and solutions that prioritise patient centricity and adherence.

2025 finalists:

• SCHOTT TOPPAC® infuse – the next generation
  SCHOTT Pharma AG & Co. KGaA
• TILE-X
  IMA LIFE
• Vytal® innovative RTU snap-fit closure
  H&T Presspart

This category recognises Start-Ups and SMEs that are driving value and innovation across the pharma value chain. We are seeking entries that showcase a clear promise of innovation, growth, or sustainable development in the pharmaceutical industry. Understanding that Start-Ups may be at various stages of development, we welcome entries across proof of concept, prototype, or commercialized stages.

2025 finalists:

• Custom, cell-free, synthetic DNA - including high complexity sequences, multi kilobase length and milligram scale - made in days to weeks
  NunaBio Ltd
• CellScrew®
  Green Elephant Biotech
• Lipids for innovative druf formulation
  NovoArc GmbH
• ORYL F1
  ORYL Photonics

This category celebrates innovation in technologies, products, processes, and services that ensure the safe handling, security, and tracking of drug substances, raw materials, and finished drug products. It includes but is not limited to, advancements in supply chain optimisation, audits, temperature-controlled logistics, transport services, shipping and storage, anti-counterfeiting measures, inventory management, demand forecasting, and distribution channels.

2025 finalists:

• Cryoport Systems' Integrated End-to-End Supply Chain Platform
  Cryoport Systems
• TraceLink Orchestration Platform for Universal Solutions (OPUS)
  TraceLink
• QYOBO platform - actionable value across the entire pharmaceutical supply chain
  QYOBO GmbH
  
• Occam Systems: Resilient Chemical Supply Chains. Supercharged by Artificial Intelligence
  Occam Systems
  

This category recognises innovation in sustainable manufacturing, production, or development within the pharmaceutical industry. It includes but is not limited to, innovative approaches to reducing environmental impact, waste, and carbon emissions; energy and utility-saving solutions; sustainable and collaborative product development; plastic reduction; improved recyclability and lifecycle management; the implementation of circular economy initiatives; innovative use of materials; safeguarding workers; and programs or initiatives aimed at improving diversity and inclusion.

2025 finalists:

• Omnilock™ Ultra PAPER
  Huhtamaki
• Sustainability Grows on Trees: Producing the Gold Standard Vaccine Adjuvant QS-21 through In-Lab Cultivation & Extraction from Quillaja saponaria trees
  Botanical Solution Inc. (BSI)
• Lean, Green and Secure: A Regulatory-Ready Blister-Free Syringe Solution
  Alliance to Zero
• J.T.Baker® Viral Inactivation Solution – Environmentally Safer Detergent for Virus Removal in Bioprocessing
  Avantor
• Enantios platform
  Enantios
  
• Leading the way in next-generation propellants (NGPs), protecting tomorrow today
  Kindeva
  
• KinetiSol™ Technology
  AustinPx
  
• Bio-based chemicals (acetone, butanol & ethanol) made from by-products and waste
  Celtic Renewables
  

This award recognises outstanding leadership within the pharma industry. We invite C-Suite executives from SMEs, large pharma/biopharma companies, and service providers to apply. The jury will be looking for examples of exceptional leadership, which may include achievements in areas such as financial performance, product success, global reach, leadership skills, management capability, charitable initiatives, sustainability, regulatory compliance, profitability, vision, marketing, acquisitions, corporate strategy, and financing.

2025 finalists:

• Michael Quirmbach
  CordenPharma International
• Lars Petersen
  FUJIFILM Diosynth Biotechnologies
• Hanns-Christian Mahler
  ten23 health
• Bobby Sheng
  Bora Pharmaceuticals
• Deepak Bahri
  Sentiss Pharma
• Lisa Soyeon Park
  Prestige Biopharma

Each generation brings a new perspective, and this award recognises the rising stars who are shaping the future of pharma with fresh approaches. We invite applications from candidates with at least five years of experience within a pharma, biopharma company, academic institution, or research setting. Entrants must be no older than 35 by the time of the Awards ceremony on 28th October 2025.

Our 2025 finalists:

• Yuvansh Khokhani
  YSK Laboratories Pvt Ltd
• Mark Kelada
  Nelipak Laboratory Services
• Yolanda Gomez
  Esteve Quimica, S.A
• Jakub Knurek
  Mabion
  
• Mohammad Farahani
  CinnaGen
  

• Christiane Bardroff
  Rentschler Biopharma
• Adriana Kiędzierska-Mencfeld
  Polpharma Biologics
• Jonina Gudmundsdottir
  Coripharma
• Meeta Gulyani
  Ecolab Life Sciences
• Jennifer Gattari
  Pfizer CentreOne
• Dr. Ivy Gao
  Sunresin